Medical Device Post Marketing Surveillance

Post marketing surveillance guidelines is a collection of processes activities used to monitor the safety effectiveness of medical devices.

Medical device post marketing surveillance.

The historical role of post market surveillance pms of medical devices has been reactive. The medical device regulation mdr lays special emphasis on gathering clinical and safety related data after the approval ce certification process and market access. The fda adverse event reporting system faers is a computerized information database designed to support the fda s post marketing safety surveillance program for all approved drug and therapeutic. Postmarketing surveillance pms also post market surveillance is the practice of monitoring the safety of a pharmaceutical drug or medical device after it has been released on the market and is an important part of the science of pharmacovigilance.

Figure 3 risk managements documents required for the market placement of a medical device compared with a. Postmarket requirements also include postmarket surveillance studies required under section 522 of the act as well as post approval studies required at the time of approval of a premarket approval. Eu postmarket surveillance plans for medical devices pdf. Post market surveillance the key to better devices it s difficult to state that by removing the equivalence rule and replacing it with a more strict clinical trial requirement similar to the pharmaceutical industry we could have safer or more effective devices.

And post market phases. In order to comply with the european union eu medical device directives 90 385 eec active implantable medical directives aimd 93 42 eec medical device directive mdd and 98 79 ec in vitro diagnostics device directive ivdd referred to as the directives hereafter manufacturers must conduct post market surveillance pms. Post market surveillance pms is an important part of the regulatory framework for medical devices in europe.